SCHEMBL10123533

SCHEMBL10123533

C=C(NNc1cccc(C#N)c1)NC(C)(C(F)(F)F)C(F)(F)F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.50
PDK2 Q15119 1/20 0.50
PDK3 Q15120 1/20 0.50
PDK4 Q16654 1/20 0.50
ALDH1A1 P00352 2/20 0.42
MAPT P10636 2/20 0.42
SLC22A12 Q96S37 1/20 0.40
ABCC9 O60706 1/20 0.39
KCNJ11 Q14654 1/20 0.39
CLK1 P49759 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
IDO1 P14902 1/20 0.38
HTT P42858 2/20 0.38
NR1H4 Q96RI1 1/20 0.38
SYK P43405 1/20 0.36
LMNA P02545 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10123534 0.81 GAA (0.43) ALDH1A1MAPTCLK1MEN1KMT2A
SCHEMBL10123569 0.79 ALDH1A1 (0.45) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL417881 0.76 PDK1 (0.66) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL7477235 0.72 PDK1 (0.57) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL10123471 0.72 PDK1 (0.63) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL10123574 0.71 GAA (0.40) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL10123572 0.71 KDM4E (0.42) ALDH1A1MAPTIDO1HTTLMNA
SCHEMBL10123578 0.71 GAA (0.42) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL28378797 0.70 MAPT (0.57) PDK1PDK2PDK3PDK4ALDH1A1
SCHEMBL13993360 0.68 PDK1 (0.62) PDK1PDK2PDK3PDK4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012060820-A1 SULFONYL SEMICARBAZIDES, SEMICARBAZIDES AND UREAS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING HEMORRHAGIC FEVER VIRUSES, INCLUDING INFECTIONS ASSOCIATED WITH ARENAVIRUSES SIGA TECHNOLOGIES, INC. (US) 2012-05-10 WO disclosed